Literature DB >> 19834041

Electrophysiological and histologic assessment of retinal ganglion cell fate in a mouse model for OPA1-associated autosomal dominant optic atrophy.

Peter Heiduschka1, Sven Schnichels, Nico Fuhrmann, Sabine Hofmeister, Ulrich Schraermeyer, Bernd Wissinger, Marcel V Alavi.   

Abstract

PURPOSE: The main disease features of autosomal dominant optic atrophy (ADOA) are a bilateral reduction of visual acuity, cecocentral scotoma, and frequently tritanopia, which have been ascribed to a progressive loss of retinal ganglion cells (RGCs) and subsequent degeneration of the optic nerve. The main disease-causing gene is OPA1. Here, we examine a mouse carrying a pathogenic mutation in Opa1 by electrophysiological measurements and assess the fate of RGCs.
METHODS: Two-year-old animals underwent a full examination by electroretinography (ERG) and visually evoked potential (VEP) measurements to assess the function of the outer and inner retina and the optic nerve. Retrograde Fluorogold labeling was performed to determine the number of surviving RGCs and to assess axonal transport by neurofilament counterstaining. Phagocytosis-dependent labeled microglial cells were identified by an Iba-1 staining.
RESULTS: ERG responses were normal in aged Opa1 mice. VEP measurements revealed significantly reduced amplitudes but no change in the latencies in contrast to extended latencies found in glaucoma. Retrograde labeling of RGCs showed a significant reduction in the number of RGCs in Opa1 mice. Long-term experiments revealed the presence of microglial cells with ingested fluorescent dye.
CONCLUSIONS: This is the first electrophysiological demonstration of a visual function deficit in aged Opa1 mice. VEP measurements and retrograde labeling experiments show that the number of RGCs is reduced whereas the remaining RGCs and axons function normally. Taken together, these findings support an ascending progress of degeneration from the soma toward the axon.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19834041     DOI: 10.1167/iovs.09-3606

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  25 in total

1.  Down-regulation of OPA1 alters mouse mitochondrial morphology, PTP function, and cardiac adaptation to pressure overload.

Authors:  Jerome Piquereau; Fanny Caffin; Marta Novotova; Alexandre Prola; Anne Garnier; Philippe Mateo; Dominique Fortin; Le Ha Huynh; Valérie Nicolas; Marcel V Alavi; Catherine Brenner; Renée Ventura-Clapier; Vladimir Veksler; Frédéric Joubert
Journal:  Cardiovasc Res       Date:  2012-03-08       Impact factor: 10.787

2.  Genome-wide linkage scan and association study of PARL to the expression of LHON families in Thailand.

Authors:  Nopasak Phasukkijwatana; Bussaraporn Kunhapan; Jim Stankovich; Wanicha L Chuenkongkaew; Russell Thomson; Timothy Thornton; Melanie Bahlo; Taisei Mushiroda; Yusuke Nakamura; Surakameth Mahasirimongkol; Aung Win Tun; Chatchawan Srisawat; Chanin Limwongse; Chayanon Peerapittayamongkol; Thanyachai Sura; Wichit Suthammarak; Patcharee Lertrit
Journal:  Hum Genet       Date:  2010-04-21       Impact factor: 4.132

Review 3.  Dominant optic atrophy.

Authors:  Guy Lenaers; Christian Hamel; Cécile Delettre; Patrizia Amati-Bonneau; Vincent Procaccio; Dominique Bonneau; Pascal Reynier; Dan Milea
Journal:  Orphanet J Rare Dis       Date:  2012-07-09       Impact factor: 4.123

4.  Contribution of retinal ganglion cells to the mouse electroretinogram.

Authors:  Benjamin J Smith; Xu Wang; Balwantray C Chauhan; Patrice D Côté; François Tremblay
Journal:  Doc Ophthalmol       Date:  2014-06       Impact factor: 2.379

5.  Differential loss of prolyl isomerase or chaperone activity of Ran-binding protein 2 (Ranbp2) unveils distinct physiological roles of its cyclophilin domain in proteostasis.

Authors:  Kyoung-in Cho; Hemangi Patil; Eugene Senda; Jessica Wang; Haiqing Yi; Sunny Qiu; Dosuk Yoon; Minzhong Yu; Andrew Orry; Neal S Peachey; Paulo A Ferreira
Journal:  J Biol Chem       Date:  2014-01-08       Impact factor: 5.157

Review 6.  Mitochondrial disorders and the eye.

Authors:  Nicole J Van Bergen; Rahul Chakrabarti; Evelyn C O'Neill; Jonathan G Crowston; Ian A Trounce
Journal:  Eye Brain       Date:  2011-09-26

Review 7.  Mitochondrial optic neuropathies - disease mechanisms and therapeutic strategies.

Authors:  Patrick Yu-Wai-Man; Philip G Griffiths; Patrick F Chinnery
Journal:  Prog Retin Eye Res       Date:  2010-11-26       Impact factor: 21.198

Review 8.  Evaluating retinal ganglion cell loss and dysfunction.

Authors:  Ben Mead; Stanislav Tomarev
Journal:  Exp Eye Res       Date:  2016-08-12       Impact factor: 3.467

9.  Solving a 50 year mystery of a missing OPA1 mutation: more insights from the first family diagnosed with autosomal dominant optic atrophy.

Authors:  Nico Fuhrmann; Simone Schimpf; York Kamenisch; Beate Leo-Kottler; Christiane Alexander; Georg Auburger; Eberhart Zrenner; Bernd Wissinger; Marcel V Alavi
Journal:  Mol Neurodegener       Date:  2010-06-14       Impact factor: 14.195

10.  Deletion of olfactomedin 2 induces changes in the AMPA receptor complex and impairs visual, olfactory, and motor functions in mice.

Authors:  Afia Sultana; Naoki Nakaya; Lijin Dong; Mones Abu-Asab; Haohua Qian; Stanislav I Tomarev
Journal:  Exp Neurol       Date:  2014-09-10       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.